Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 7,500 shares at $40.18 ($301K) on 2020-05-08, disclosed to the SEC on 2020-05-12.
Open-market sale of $301k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.18 | 7,000 | $281K | 93.4% |
| 2 | $40.00 | 500 | $20K | 6.6% |
| Total | $40.17 avg | 7,500 | $301K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |